Pfcrt K76T and Pfmdr 1 Resistance Genes in Post Chloroquine Era in South-South Region of Nigeria
Tolulope Alade, Ewaoche Sunday Itodo, Ebidor Lawani, Gloria Adie, Mirabeau Youtchou Tatfeng
International Journal of TROPICAL DISEASE & Health · pp. 1–11 · Published 30 Nov 2019
10.9734/ijtdh/2019/v39i330208Abstract
Malaria, a global health problem especially in the sub-Sahara region has been posing a recurrent problem due to the resistance of the parasites to the available antimalarial drugs despite the preventive measures provided by WHO. Aims: This study is aimed at determining the prevalence of resistance markers in four Niger Delta states of Nigeria, a decade after withdrawal of chloroquine. Methods: Eight hundred and forty six (846) subjects participated in the study and were distributed as follows, 192(22.7%) Bayelsa; 218(25.8%) Rivers; 196(23.2%) Edo and 240(28.4%) Delta respectively. Malaria parasite identification was carried out using standard parasitological techniques. Genotyping of the resistance markers Pfcrt K76T and Pfmdr 1 was carried out by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP). Results: Our findings revealed that the prevalence of malaria infection in the four Niger Delta states were 78.1%, 68.8%, 62.8% and 58.8% in Bayelsa, Rivers States, Edo and Delta respectively. There was no statistical difference in the prevalence of malaria within the four Niger Delta states. (P>0.05). Children below the age of 5 years recorded the highest infection rates when compared to subjects in other age groups (P< 0.01). Our findings also revealed that the distribution of mutant Pfcrt K76T and Pfmdr 1 genes across the four states were 12.0% and 28.6%, 4.0% and 22.0%, 14.6% and 29.3%, 10.6% and 25.0% in Bayelsa, Rivers, Edo and Delta state respectively. However, the prevalence of Pfcrt K76T in Rivers State was statistically lower when compared to other states (P < 0.01) while no statistical difference existed in the distribution of Pfmdr 1 mutant genes (P>0.01). Conclusion: Prevalence of Pfcrt and Pfmdr 1 remained elevated in the Niger Delta states despite the withdrawal of chloroquine over a decade ago. Hence, Nigeria is far from an eventual re-introduction of chloroquine as its resistance markers still persist in our communities. Furthermore, the root cause of the persistence of these resistance markers needs to be investigated.
References (4)
- 1 Reemergence of Chloroquine‐Sensitive Plasmodium falciparum Malaria after Cessation of Chloroquine Use in Malawi [DOI]
- 2 Principal component analysis of socioeconomic factors and their association with malaria in children from the Ashanti Region, Ghana [DOI]
- 3 Laboratory Diagnosis of Malaria: Conventional and Rapid Diagnostic Methods [DOI]
- 4 Mechanisms of Quinoline Resistance [DOI]
Cited by 0
No indexed citations yet.
Related research
- Screening for Hepatitis B Virus among HIV Infected Women Seeking Antiretroviral Therapy at National Institute for Pharmaceutical Research and Development, Abuja, Nigeria — shares topic coverage
- Urinary Pathogens amongst Parturients at the University of Port Harcourt Teaching Hospital, South-South, Nigeria — shares topic coverage
- Risk Factors of Hypertension among Type 2 Diabetic Patients in Imo state, South East of Nigeria — shares topic coverage
- Willingness to Participate and Pay into a Community- Based Health Insurance Scheme in Imesi-Ile, a Rural Community in Osun State, Nigeria — shares topic coverage
- Prevalence and Comorbidity of Depression and Anxiety among Medical Students in Babcock University, Ogun State, Nigeria — shares topic coverage
Article metrics
Real usage data collected on this platform.
19
Page views
0
PDF downloads
3
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.